Predicted to have endopeptidase activity and lipopolysaccharide binding activity. Predicted to be involved in negative regulation of inflammatory response to antigenic stimulus; proteasomal ubiquitin-independent protein catabolic process; and proteasome-mediated ubiquitin-dependent protein catabolic process. Predicted to localize to several cellular components, including ciliary basal body; nucleus; and proteasome core complex, beta-subunit complex. Orthologous to human PSMB4 (proteasome 20S subunit beta 4); PARTICIPATES IN ubiquitin/proteasome degradation pathway; INTERACTS WITH 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane; 2,3,7,8-tetrachlorodibenzodioxine; 2,4,6-trinitrotoluene.
[Clofibrate co-treated with Acetaminophen] affects the expression of PSMB4 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PSMB4 mRNA]
[Clofibrate co-treated with Acetaminophen] affects the expression of PSMB4 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PSMB4 mRNA]
PPARA protein affects the reaction [perfluorooctanoic acid results in increased expression of PSMB4 mRNA], PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of PSMB4 mRNA]
PPARA protein affects the reaction [pirinixic acid results in increased expression of PSMB4 mRNA], PPARA protein promotes the reaction [pirinixic acid results in increased expression of PSMB4 mRNA]
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Founder strain for the heterogeneous stock (HS) rat population; SNPs from the RGSC 3.4 assembly were "lifted over" from RGSC 3.4 to Rnor 5.0 and from Rnor 5.0 to Rnor 6.0; Provided by Medical College of Wisconsin
Gene-Chemical Interaction Annotations
